Study on Oral IRAK-4 Inhibitor CA-4948 with Pembrolizumab After Brain Radiation in Melanoma Patients | Clinical Trial

Study on Oral IRAK-4 Inhibitor CA-4948 with Pembrolizumab After Brain Radiation in Melanoma Patients | Clinical Trial | Right2Hope